European Journal of Clinical and Experimental Medicine T.16, z. 1 (2018)

URI dla tej Kolekcjihttp://repozytorium.ur.edu.pl/handle/item/3872

Przeglądaj

Przeglądanie European Journal of Clinical and Experimental Medicine T.16, z. 1 (2018) według Autor "Aebisher, David"

Wpisz kilka pierwszych liter i kliknij przycisk Przeglądaj
Aktualnie wyświetlane 1 - 5 z 5
  • Obrazek miniatury
    Pozycja
    Anticancer properties of Viburnum
    (Wydawnictwo Uniwersytetu Rzeszowskiego, 2018) Stępień, Agnieszka; Aebisher, David; Bartusik-Aebisher, Dorota
    Aim. The aim of this paper is to provide an overview of the anticancer properties of different species of Viburnum. Materials and methods. Forty nine papers that discuss the medicinal history and current research of Viburnum species as phytotherapeutic agent were used for this discussion. Literature analysis. The results of scientific research conducted in vitro indicate that the compounds present in the extracts of Viburnum significantly affect the development of cancer cells such as leukemia, cervical cancer, breast, colon, lung, skin and stomach. This indicates that they may be used as a therapeutic agent to support oncological therapies.
  • Obrazek miniatury
    Pozycja
    Fundamentals of the use of Berberis as a medicinal plant
    (Wydawnictwo Uniwersytetu Rzeszowskiego, 2018) Bober, Zuzanna; Stępień, Agnieszka; Aebisher, David; Ożóg, Łukasz; Bartusik-Aebisher, Dorota
    Introduction. The daily use of medicinal plants has increased in recent years. The study of drugs of natural origin as an academic discipline and its applications in healthcare has changed remarkably but still focus on the quality of products and the development of new medicines. Aim. This study covers all fundamental aspects of pharmacognosy as well as topics relating to the therapeutic use of plant drugs known as phythotherapy. The purpose of the study was to review the literature about the use of Berberis. Materials and method. We reviewed the literature regarding the use of Berberis published between 1933 and 2018. We found more than 500 articles studying the properties of Berberis for digestive disorders, antibacterial, antidiabetic, hypotensive effects, anti-inflammatory effects, cholesterol regulation, cardiovascular disease, hyperlipidemia, cerebral ischemia trauma, mental disease, Alzheimer disease and osteoporosis. Our review includes recent studies regarding chemical composition and medicinal outcomes of Berberis.
  • Obrazek miniatury
    Pozycja
    Plant medicinal products and drug interactions
    (Wydawnictwo Uniwersytetu Rzeszowskiego, 2018) Ożóg, Łukasz; Aebisher, David; Bober, Zuzanna; Bartusik-Aebisher, Dorota
    Introduction. Some herbal medicinal products may be beneficial in certain respects but many can be dangerous for patients taking doctor-prescribed medications. Plant medicinal products are often taken with conventional drugs by patients. Interactions are possible between herbal medicinal products and conventional medications that can lead to toxicity due to increased drug plasma levels or drug treatment failure. Aim. The aim of the study was to review the study of plant medicinal products and drug interactions. Materials and method. Analysis of literature.
  • Obrazek miniatury
    Pozycja
    Plants – a source of therapeutic material?
    (Wydawnictwo Uniwersytetu Rzeszowskiego, 2018) Bober, Zuzanna; Stępień, Agnieszka; Aebisher, David; Ożóg, Łukasz; Bartusik-Aebisher, Dorota
    Introduction. The use of plants with therapeutic or medicinal properties is as ancient as human civilization and for many years prior to the 20th century, plants and animal products were the main source of therapeutic medicinal drugs. Aim. The discovery of new plant-derived drugs continues to be an active field of research in medical science today. The aim of this article is to describe several main classes of natural products currently under investigation. Material and methods. Analysis of literature.
  • Obrazek miniatury
    Pozycja
    The significance of NGAL and KIM-1 proteins for diagnosis of acute kidney injury (AKI) in clinical practice
    (Wydawnictwo Uniwersytetu Rzeszowskiego, 2018) Kubrak, Tomasz; Podgórski, Rafał; Aebisher, David; Gala-Błądzińska, Agnieszka
    Introduction. Despite advances in medical care AKI (acute kidney injury) is associated with high morbidity and mortality. The lack of adequate early renal injury biomarkers is often a problem for an early AKI diagnosis. In recent years, numerous scientific studies have been carried out which reveal new urine and serum markers to assess the period of the kidney injury before revealing its late clinical effects. In most clinical settings, AKI is due to acute renal tubular necrosis which results in protein accumulation in urine. Determination of the concentrations of proteins such as NGAL (neutrophil gelatinase-associated lipocalin) and KIM-1 (kidney injury molecule-1) are of great significance in the diagnosis of AKI. Aim. The purpose of the study was to review the literature about significance of NGAL and KIM-1 proteins for diagnosis of acute kidney injury (AKI) in clinical practice. Materials and method. Analysis of Polish and foreign literature.